Phase I study of temozolomide in conjunction with gemcitabine
Rajesh Kumar Goel(Punjabi University), David L. Cutler(Athenex (United States)), A. Rodgers, Geraldine Goss, C. Cripps(Canadian Partnership Against Cancer), Scott A. Laurie(Ottawa Hospital), David J. Stewart(University of Ottawa), S. Gertler(Ottawa Regional Cancer Foundation), Dominique Bédard, Neil Reaume
Cited by 0
Related Papers
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.9k
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial
|The Lancet Oncology|2016|1.2k
Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer
|Journal of Clinical Oncology|1999|960
Wnt Signaling Pathway in Non-Small Cell Lung Cancer
|JNCI Journal of the National Cancer Institute|2013|659
American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer
|Journal of Clinical Oncology|2006|504